Savera Pharmaceuticals Private Limited

Savera Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1996PTC097697 Incorporated 27 February 1996 ROC Mumbai HQ Aurangabad, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹11.53 Cr
▲ 87% YoY
Net profit · FY 2025
₹98.78 Lakh
Net margin 8.6%
EBITDA · FY 2025
₹2.38 Cr
EBITDA margin 20.7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.9 Cr
Issued & subscribed
Open charges
₹13.29 Cr
Satisfied ₹27.15 Cr
Company age
30 yrs
Est. 1996
Directors on board
5
As per MCA filings

About Savera Pharmaceuticals Private Limited

Data last updated:

Savera Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1996PTC097697. Its GSTIN is 27AACCS7967B1Z6 (Maharashtra).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.9 Cr. It is led by directors including Anil Moreshwar Save and Rajeev Yadav Churi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Anjali Complexkhandkeshwar, Aurangabad, Maharashtra, India – 431001.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.53 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹98.78 Lakh (net margin 8.6%) and EBITDA of ₹2.38 Cr (EBITDA margin 20.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 5% over five years.

The company is associated with 1 brand: Savera Pharmaceuticals. As per MCA filings, the company has open charges of ₹13.29 Cr and satisfied charges of ₹27.15 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saverapharma.com.

Company details

CIN U24230MH1996PTC097697
Registration Number 097697
Incorporation Date 27 February 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Savera Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its website is saverapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Anjali Complexkhandkeshwar, Aurangabad, Maharashtra, India – 431001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Savera Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Savera Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Savera Pharmaceuticals operates one associated brand: Savera Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Contract manufacturing of liquid oral and powder formulations for pharmaceuticals.saverapharma.com

Business activity

The main business activity of Savera Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Savera Pharmaceuticals Private Limited, buy the company report.

Financials of Savera Pharmaceuticals Private Limited

FY 2025 filings available

Savera Pharmaceuticals Private Limited reported revenue of ₹11.53 Cr (up 87% YoY) for FY 2025.

Revenue · FY 2025
₹11.53 Cr ▲ 87%
Net profit · FY 2025
₹98.78 Lakh margin 8.6%
EBITDA · FY 2025
₹2.38 Cr margin 20.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 87%
3 years · compounded
▲ 18%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 271%
3 years · compounded
▲ 39%
5 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 87% growth in the latest year. EBITDA rose 271% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.38 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹98.78 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20.7%
Net Profit Margin8.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Savera Pharmaceuticals Private Limited, buy the company report.

Board of directors of Savera Pharmaceuticals Private Limited

Savera Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anil Moreshwar SaveDirector27 Feb 199630 Years 8 MonthsCurrent
Rajeev Yadav ChuriDirector27 Feb 199630 Years 8 MonthsCurrent
Ajit Moreshwar SaveDirector27 Feb 199630 Years 8 MonthsCurrent
Arpit Anil SaveDirector17 Jan 20242 Years 9 MonthsCurrent
Anjali Anil SaveDirector30 Sep 20188 Years 0 MonthsCurrent

Peer comparison

Savera Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MC Coy Drugs Private Limited₹11.59 Cr (FY 2025)70.0%Surat, Gujarat, India
Yaxon Bio Care Private Limited₹11.57 Cr (FY 2025)8.0%Delhi, India
Savera Pharmaceuticals Private Limitedthis company₹11.53 Cr (FY 2025)₹98.78 Lakh8.6%87.0%Aurangabad, Maharashtra, India
Hindustan Medicines Private Limited₹11.49 Cr (FY 2025)9.0%Kolkata, West Bengal, India
Accuwell Medics Private Limited₹11.48 Cr (FY 2024)89.0%Changodar, Gujarat, India

To see the full peer comparison of Savera Pharmaceuticals Private Limited, buy the company report.

Auditor

Savera Pharmaceuticals Private Limited is audited by Ashok Patil & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Ashok Patil & AssociatesFY 2024122045W

Shareholding

The shareholding of Savera Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Savera Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹13.29 Cr
Satisfied charges
₹27.15 Cr
Breakdown by lending institutions
Others₹13.29 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Nov 2025101202715Others₹35 LakhOpen
15 Jul 2025101125945Others₹1.53 CrOpen
13 Dec 2024101056823Others₹33.5 LakhOpen
16 Sep 2024100985551Others₹32.3 LakhOpen
31 Oct 2019100303436Others₹4 CrOpen

To see the full charge records of Savera Pharmaceuticals Private Limited, buy the company report.

Total charge records: 24 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Savera Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Savera Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AACCS7967B1Z6MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Savera Pharmaceuticals Private Limited, buy the company report.

Recent activity

Savera Pharmaceuticals Private Limited has 7 board changes on record since 1996: 5 appointments and 2 cessations. The latest: Arpit Anil Save was appointed as Director on 17 Jan 2024.

Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 101202715 was registered on 12 Nov 2025.
AGM
Savera Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.53 Cr with Charge ID 101125945 was registered on 15 Jul 2025.
Charges
A charge with Others of Rs. 4.00 Cr registered on 31 Oct 2019 with Charge ID 100303436 was modified on 15 Jul 2025.
Filing
Savera Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.34 Cr with Charge ID 101056823 was registered on 13 Dec 2024.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 100985551 was registered on 16 Sep 2024.
Appointed
Arpit Anil Save was appointed as Director.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100303436 was registered on 31 Oct 2019.
Charges
A charge with Others of Rs. 1.63 Cr registered on 14 Jan 2019 with Charge ID 100243787 was modified on 30 Oct 2019.
Charges
A charge with Others of Rs. 1.59 Cr registered on 20 Feb 2018 with Charge ID 100185402 was modified on 30 Oct 2019.
Charges
A charge with Others of Rs. 0.85 Cr registered on 27 Oct 2015 with Charge ID 10621752 was modified on 30 Oct 2019.

47 earlier events are in the company report.

Frequently asked questions

Savera Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 February 1996 (30+ years old) and is registered under CIN U24230MH1996PTC097697.

Savera Pharmaceuticals has 5 current directors:

The latest financial statements of Savera Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Savera Pharmaceuticals is 27AACCS7967B1Z6, registered in Maharashtra.

The CIN (Corporate Identification Number) of Savera Pharmaceuticals is U24230MH1996PTC097697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Savera Pharmaceuticals has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending.

Savera Pharmaceuticals was incorporated on 27 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Savera Pharmaceuticals by revenue are MC Coy Drugs Private Limited, Yaxon Bio Care Private Limited, Hindustan Medicines Private Limited, Accuwell Medics Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Arpit Anil Save was appointed as Director on 17 Jan 2024. Anjali Anil Save was appointed as Director on 30 Sep 2018. Anil Moreshwar Save ceased to be Managing Director on 02 Aug 2017. Savera Pharmaceuticals has 7 board changes on record in total.

Savera Pharmaceuticals can be reached through the website saverapharma.com. Its registered office is in Aurangabad, Maharashtra, India.

The registered office of Savera Pharmaceuticals is at Anjali Complexkhandkeshwar, Aurangabad, Maharashtra, India – 431001.